Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons

Virus Research

Volumn 103, Issue 1-2, 2004, Pages 195-197

  Mungall, Bruce A ^a   Xu, Xiyan ^a   Klimov, Alexander ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Influenza surveillance; Neuraminidase Inhibitor; Osetamivir; Zanamivir

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; SIALIDASE INHIBITOR; ZANAMIVIR;

ANIMAL CELL; CHEMOLUMINESCENCE; CONFERENCE PAPER; DOG; HEALTH SURVEY; IC 50; INFLUENZA; INFLUENZA VIRUS A; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VIRUS ISOLATION; VIRUS TITRATION;

ACETAMIDES; ANTIVIRAL AGENTS; CHEMILUMINESCENT MEASUREMENTS; ENZYME INHIBITORS; GUANIDINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; NEURAMINIDASE; OSELTAMIVIR; POPULATION SURVEILLANCE; PYRANS; SIALIC ACIDS; ZANAMIVIR;

ANIMALIA; CANIS FAMILIARIS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VIRUS; RNA VIRUSES;

EID: 2442562124     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.02.033     Document Type: Conference Paper

References (7)

1. Buxton R.C., Edwards B., Juo R.R., Voyta J.C., Tisdale M., Bethell R.C. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir. Anal. Biochem. 280(2):2000;291-300
2. Covington E., Mendel D.B., Escarpe P., Tai C.Y., Soderbarg K., Roberts N.A. Phenotypic and genotypic assay of influenza virus neuraminidase indicates a low incidence of viral drug resistance during treatment with oseltamivir. J. Clin. Virol. 18:2000;P-326
3. Gubareva L.V., Robinson M.J., Bethell R.C., Webster R.G. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. J. Virol. 71:1997;3385-3390
4. Gubareva L.V., Matrosovich M.N., Brenner M.K., Bethell R.C., Webster R.G. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J. Infect. Dis. 178:1998;1257-1262
5. Jackson H.C., Roberts N., Wange Z.M., Belshe R. Management of influenza: use of new antivirals and resistance in perspective. Clin. Drug Invest. 20:2000;447-454
6. McKimm-Breschkim J.L. Resistance of influenza viruses to neuraminidase inhibitors - a review. Antiviral Res. 47:2000;1-17
7. Xu X., Smith C.B., Mungall B.A., Lindstrom S.E., Hall H.E., Subbarao K., Cox N.J., Klimov A. Intercontinental circulation of human influenza A (H1N2) reassortant viruses during the 2001-2002 influenza season. J. Infect. Dis. 186:2002;1490-1493